Abstract B64: Evaluation of doxorubicin and PD-1/CTLA-4 immune blockade combination therapy in the MCA-205 murine model

MLA

Nicholas R Therrien, et al. “Abstract B64: Evaluation of Doxorubicin and PD-1/CTLA-4 Immune Blockade Combination Therapy in the MCA-205 Murine Model.” Cancer Immunology Research, vol. 10, Dec. 2022, p. B64. EBSCOhost, https://doi.org/10.1158/2326-6074.tumimm22-b64.

APA

Nicholas R Therrien, Kyle Powers, Lindsey Kemp, Cristiam Moreno Tellez, & Breelyn A Wilky. (2022). Abstract B64: Evaluation of doxorubicin and PD-1/CTLA-4 immune blockade combination therapy in the MCA-205 murine model. Cancer Immunology Research, 10, B64. https://doi.org/10.1158/2326-6074.tumimm22-b64

Chicago

Nicholas R Therrien, Kyle Powers, Lindsey Kemp, Cristiam Moreno Tellez, and Breelyn A Wilky. 2022. “Abstract B64: Evaluation of Doxorubicin and PD-1/CTLA-4 Immune Blockade Combination Therapy in the MCA-205 Murine Model.” Cancer Immunology Research 10 (December): B64. doi:10.1158/2326-6074.tumimm22-b64.